Why We Invested in TRAK: Pioneering the Future of Hybrid Rehabilitation
At Decelera we’ve been lucky to have in our programs startups and founders from the evolving landscape of digital health and rehabilitation, a standout innovation caught our attention in Menorca during the 2022 Decelera program, our now Alumni Startup TRAK. This groundbreaking platform is reshaping how physiotherapy services are delivered and experienced. Here’s why TRAK represents not just a promising venture, but a revolutionary step forward in hybrid rehabilitation.
Team First
An extremely talented founding team comprised of Jon, Carlos, and Dani is at the heart of Trak’s success. Their remarkable resilience, passion for the project, outstanding leadership skills, and high level of openness serve as the driving forces behind the company. Their dedication and vision are not only inspiring but also essential for the ongoing growth of the company.
Innovative Approach to Rehabilitation
TRAK’s unique selling proposition is its ability to democratize rehab from the comfort of one’s home, eliminating the need for wearables. This hybrid rehabilitation method is a game-changer, making it accessible and convenient for users to engage in their recovery processes without the added hassle of managing wearable technology.
Proprietary Technology with High Barriers to Entry
At the core of TRAK’s success is its strong technology — a proprietary algorithm that distinguishes it from competitors. This innovation has not only created high barriers to entry but has also been acknowledged by clients who affirm that no other company offers anything similar. This uniqueness positions TRAK as a leader in its field.
Product Stickiness and User Engagement
The stickiness of TRAK’s product is evident, with clinical centers reporting that around 60% of users continue to engage with the product. This high retention rate underscores the effectiveness and user satisfaction of TRAK’s platform, highlighting its importance in the rehabilitation process.
Expansive Market Potential
TRAK operates within an attractive and large addressable market, boasting a Total Addressable Market (TAM) of $6.9 billion. With the global physiotherapy services market expected to reach $166 billion by 2023 at a CAGR of 5.34%, and the digital health market set to surpass $500 billion in 2024, the growth potential is immense. This expansive market opportunity makes TRAK an enticing investment.
Sector Attractiveness: Growth and M&A Prospects
The rehabilitation sector is not only growing rapidly but is also a hotbed for mergers and acquisitions, often seeing high multiples (avg. 25x). This environment signals a very attractive sector for investment, with TRAK well-positioned to benefit from these dynamics.
Clean Captable
TRAK’s clean cap table, characterized by a non-diluted founder team and minimal small shareholders, presents a robust foundation for growth. Additionally, the presence of other strategic investors underscores the confidence in TRAK’s vision and its execution capabilities.
Explosive Growth in Spanish and LATAM Markets
With projections indicating hypergrowth (400–800%) in the next two years within the Spanish market and LATAM, TRAK is on the brink of scaling dramatically. This growth is driven by a strong pipeline and the promise of recurrent revenues, painting a bright future for the company.
Solving Industry Pain Points
At its heart, TRAK addresses a critical bottleneck in the physiotherapy industry. It enables physiotherapists to monitor more patients efficiently, overcoming time constraints and improving patient care. TRAK empowers professionals to prioritize urgent cases while still providing excellent care to all.
Our investment in TRAK is not merely a financial decision; it’s a belief in a future where rehabilitation is accessible, efficient, and integrated seamlessly into our lives. TRAK’s innovative approach, proprietary technology, and significant market potential underscore its capacity to lead and transform the rehabilitation sector. As we embark on this journey with TRAK, we are not just investing in a company; we are investing in the future of health and wellness.